Literature DB >> 11050953

Adenovirus vectors for human gene therapy.

M M Hitt1, F L Graham.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11050953     DOI： 10.1016/s0065-3527(00)55014-3

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  15 in total

1.  Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.

Authors:  Nikita Avvakumov; Russ Wheeler; Jean Claude D'Halluin; Joe S Mymryk
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 3.  Current strategies and future directions for eluding adenoviral vector immunity.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

Review 4.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

5.  Adenovirus vector designed for expression of toxic proteins.

Authors:  D Edholm; M Molin; E Bajak; G Akusjärvi
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 6.  Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Authors:  Maria G Castro; Marianela Candolfi; Thomas J Wilson; Alexandra Calinescu; Christopher Paran; Neha Kamran; Carl Koschmann; Mariela A Moreno-Ayala; Hikmat Assi; Pedro R Lowenstein
Journal:  Expert Opin Biol Ther       Date:  2014-04-29       Impact factor: 4.388

7.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.

Authors:  Nagendra R Hegde; David C Johnson
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice.

Authors:  Abraham Yang; Gabriel Gyulay; Mark Mitchell; Elizabeth White; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Lipid Res       Date:  2012-09-14       Impact factor: 5.922

Review 10.  Ebola virus vaccines - reality or fiction?

Authors:  Chad E Mire; Thomas W Geisbert; Heinz Feldmann; Andrea Marzi
Journal:  Expert Rev Vaccines       Date:  2016-05-09       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.